Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.031 | 0.7 |
mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |